期刊
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 180, 期 -, 页码 524-535出版社
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2019.07.034
关键词
Curcumin; Analogues; Structural modification; Anticancer activity
资金
- Science and Technology Fund for Distinguished Young Scholars of Sichuan Province [2017JQ0013]
- Scientific Research Foundation of the Education Department of Sichuan Province [17ZA0439, 18ZB0646]
- Traditional Chinese Medicine Administration in Sichuan Province [2018QN069]
- Southwest Medical University [2017LZXNYD-T02]
- Luzhou City [2017LZXNYD-T02]
Curcumin (CU), an edible natural pigment from Curcuma Longa, has demonstrated extensive anti-tumor effect in vivo and in vitro. With the property of reversing drug resistance and low toxicity, CU has been considered to develop a new adjuvant chemotherapy protocol of cancer. However, the poor stability, solubility, in vivo bioavailability and weak activity of CU greatly limit its clinical application. Therefore, CU analogues have been extensively studied. Starting from the study of natural CU analogues, multiple approaches are being sought to obtain more stable, soluble and effective analogues of CU. This review focuses on the progress of these approaches to more potent CU analogues. (C) 2019 Elsevier Masson SAS. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据